Therapure Biopharma Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Therapure Biopharma's estimated annual revenue is currently $20M per year.(i)
  • Therapure Biopharma's estimated revenue per employee is $155,000

Employee Data

  • Therapure Biopharma has 129 Employees.(i)
  • Therapure Biopharma grew their employee count by -12% last year.

Therapure Biopharma's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.7M9-72%$39.4MN/A
#2
$0.9M11-83%$23.8MN/A
#3
$87.6M5656%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$7.8M50-68%N/AN/A
#6
$13.5M8730%N/AN/A
#7
$17.8M115-6%N/AN/A
#8
$0.9M11-39%N/AN/A
#9
$13.6M88-20%$86MN/A
#10
$20M129-12%N/AN/A
Add Company

What Is Therapure Biopharma?

Therapure is an integrated Contract Development and Manufacturing Organization (CDMO) that helps develop and manufacture therapeutic proteins for biopharmaceutical companies of all sizes. \r\n\r\nTherapure offers a range of therapeutic protein production services at clinical through commercial scale, including:\r\n\r\n• Technology Transfer & Process Development\r\n• Analytical Development & Testing\r\n• Scale Up & cGMP Manufacturing\r\n• Aseptic Fill/Finish & Lyophilization\r\n• Support Services\r\n\r\nTherapure has experience utilizing a variety of different sources of API including: mammalian cell culture, whole blood and plasma and primary cell culture. Therapure has a proven track record working with small biotech companies through to multinationals. Therapure was founded in 2008 and operates a 130,000 square foot cGMP facility in Mississauga, Ontario, Canada.

keywords:N/A

N/A

Total Funding

129

Number of Employees

$20M

Revenue (est)

-12%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Therapure Biopharma News

2022-04-20 - Chemotherapy Induced Anemia Market Size, Outlook And ...

... Dr. Reddy's Laboratories, Pfizer, Panacea Biotec, 3SBio, SBI Pharmaceuticals, Tolero Pharmaceuticals, Vifor Pharma, Therapure Biopharma.

2022-04-17 - Artificial Blood Substitutes Market In-Depth Analysis and ...

alliance pharma plc, baxter, NuvOx Pharma, Sanguine Biosciences, Therapure Biopharma Inc, Hemarina, Hemoglobin Oxygen Therapeutics,...

2015-11-27 - Therapure Biopharma Files Preliminary Prospectus for IPO

Canadian biopharmaceutical company Therapure Biopharma, Inc., has filed a preliminary prospectus with securities regulatory authorities in each of the provinces and territories of Canada in connection with a proposed initial public offering of its common shares. The offering is being made throu ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$34.8M129-4%N/A
#2
$39.7M1302%N/A
#3
$31.9M1306%N/A
#4
$33.1M131-2%N/A
#5
$15M1316%N/A